Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease [Phase 2]
Phase 2 clinical trial update evaluating extracorporeal photopheresis for children and young adults with refractory acute graft-versus-host …
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant [Phase 1]
Phase 1 trial evaluating donor mesenchymal stem cell infusions for acute or chronic graft-versus-host disease after donor stem cell transpla…
-
FDA approval · 2010-10-12FDA Approved: REVLIMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for REVLIMID (lenalidomide) submitted by Celgene Corporation.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study evaluating donor white blood cell infusions with interleukin-2 in patients undergoin…
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial evaluating methotrexate with glucocorticoids for newly diagnosed acute graft-versus-host disease after donor stem c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation [NA]
This clinical trial update evaluates mycophenolate mofetil for preventing graft-versus-host disease in high-risk allogeneic stem cell transp…
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation [NA]
A clinical trial update describing the use of Basiliximab for treating acute graft-versus-host disease after allogeneic stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Campath-1H + FK506 and Methylprednisolone for GVHD [Phase 2]
Completed Phase 2 clinical trial evaluating Campath-1H plus tacrolimus (FK506) and methylprednisolone for graft-versus-host disease.
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating the combination of alemtuzumab with glucocorticoids for newly diagnosed acute graft-versus-host disease af…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer [Phase 2]
This Phase 2 trial evaluates a conditioning regimen with fludarabine and busulfan followed by donor peripheral stem cell transplantation wit…
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 2]
A Phase 2 trial evaluating tacrolimus and mycophenolate mofetil to prevent acute graft-versus-host disease in patients with advanced hematol…
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) [Phase 2]
Phase 2 clinical trial update for treatment of acute graft-versus-host disease (BMT CTN 0302) completed with results posted in 2010.
-
CLINICAL_TRIALS research · 2010-04-02Clinical Trial Update: Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated beclomethasone for treating graft-versus-host disease affecting the GI tract from the esophagus to the…
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation [Phase 3]
A Phase 3 trial evaluating budesonide to prevent acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating cyclophosphamide and/or mycophenolate mofetil with or without tacrolimus in patients undergoing donor bone…
-
CLINICAL_TRIALS research · 2010-01-28Clinical Trial Update: Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [Phase 2]
A Phase 2 clinical trial update evaluating stem cell transplantation for hematological cancers or related disorders, listing conditions such…
-
CLINICAL_TRIALS trial_result · 2009-11-20Clinical Trial Update: Tissue Repair in Stem Cell Transplant Recipients [NA]
The trial assessing tissue repair in stem cell transplant recipients for graft-versus-host disease has been terminated and results were post…
-
CLINICAL_TRIALS research · 2009-10-01Clinical Trial Update: Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation [Phase 2]
Phase 2 clinical trial update on adjusting cyclosporine dosing according to calcineurin activity after allogeneic hematopoietic stem cell tr…
-
CLINICAL_TRIALS trial_result · 2009-09-07Clinical Trial Update: Study Evaluating Sirolimus in Kidney Transplant Recipients [Phase 3]
Phase 3 clinical trial update evaluating sirolimus in kidney transplant recipients has completed, with results posted in 2009. The study als…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) [Phase 3]
Phase 3 trial of mycophenolate mofetil for chronic graft-versus-host disease in cancer patients was terminated, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients [Phase 4]
A Phase 4 trial evaluating sirolimus in end-stage renal disease among high-risk kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients [Phase 3]
A Phase 3 study evaluating sirolimus (Rapamune) in solid organ transplant recipients has completed. The listed conditions include graft-vers…
-
CLINICAL_TRIALS research · 2009-08-11Clinical Trial Update: Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating allogeneic mesenchymal stem cells for graft-versus-host disease; the current status of the trial is no…
-
CLINICAL_TRIALS research · 2009-07-09Clinical Trial Update: The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)
A clinical trial update exploring CK18F as a predictor of graft-versus-host disease in allogeneic stem cell transplantation.
-
CLINICAL_TRIALS research · 2009-07-08Clinical Trial Update: Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation [Phase 3]
Phase 3 randomized trial evaluating anti-thymocyte globulin (ATG) for prevention of graft-versus-host disease in pediatric patients receivin…